SEC was the one and only play left for the detractors toohot, so it was being repeated ad nauseam. It just got Blown Out of the Water with the Supreme Court decision to Hear a case claiming SEC AP Judges are unconstitutional.
Look at the Nails that have been Driven into their Coffin over the last 12 months:
* NHS Approval, the most respected healthcare provider in the world says ActiPatch is worth paying for to improve Pain Management Care
* FDA Clearance, the most respected government regulator of medical products in the world says ActiPatch is a Safe and Effective Pain Reliever
* ANDA Distribution, ActiPatch is now available through the US National Distributor ANDA with 60,000 Commercial Retail Customers
* Keith Nalepka, 15 years of experience in placing products on retail shelves. Keith knows the store buyers and can get access. First big Deal, ANDA Distribution
* Tesco, another prominent UK retailer signs up for ActiPatch, number 5 in global retail sales with $72 billion
* PharmEvo ActiPatch Licensing, first ActiPatch licensing deal, PharmEvo is selling ActiPatch under the 'Pain Gear' name, running its own Clinical Studies and Physician Education Seminars
* Back Study Completion, 100 patient Back Study has been completed, results to be issued any day
* US Amazon Sales, ActiPatch available on the world's largest online marketplace with fulfillment by Amazon
* Try and Tell, the same marketing program that launched ActiPatch in the UK is initiated in the US with a 7 Day Trial Device available for just a $4.95 shipping/handling fee
* POTUS Declares Opioid Health Emergency, the Opioid Epidemic is finally being taken seriously by the government, Opioids reduce pain in most people but their addictive nature kills dozens of Americans each
day and Opioids have numerous other negative side effects
*BIEL Announces Drug Free Solution to the Opioid Crisis, BIEL promotes ActiPatch as a safe and effective alternative to Opioids, ActiPatch has zero side effects and zero deaths from its use.
* Migraine Study Initiated, Migraine prevention is a massive potential market for ActiPatch with 36 million Americans afflicted by these debilitating headaches
* Allay Menstrual Pain Study Initiated, this study is being conducted by the Birmingham Women’s Hospital UK, a NHS Foundation Hospital, the NHS could soon be adding another Covered Indication for ActiPatch
AI
